ArticleAntimicrobial agents and chemotherapy2007
Dissemination of Acinetobacter baumannii clones with OXA-23 Carbapenemase in Colombian hospitals.
Article in Antimicrobial agents and chemotherapy, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 91 citations in OpenAlex.
- Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals.Molecular biology reports · 2021Review
- Emergence, molecular mechanisms and global spread of carbapenem-resistantMicrobial genomics · 2019Review
- Integrated pharmacokinetic-pharmacodynamic modeling to evaluate empiric carbapenem therapy in bloodstream infections.Infection and drug resistance · 2018Article
- Characterization of multidrug-resistantColombia medica (Cali, Colombia) · 2017Article
- Prevalence ofIranian journal of microbiology · 2017Article
- Association between infections caused by multidrug-resistant gram-negative bacteria and mortality in critically ill patients.World journal of critical care medicine · 2016Review
- In vitro pharmacodynamics of various antibiotics in combination against extensively drug-resistant Klebsiella pneumoniae.Antimicrobial agents and chemotherapy · 2015Article
- Antimicrobial active herbal compounds against Acinetobacter baumannii and other pathogens.Frontiers in microbiology · 2015Review
- OXA β-lactamases.Clinical microbiology reviews · 2014Review
- In memoriam: John P. Quinn, MD.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2014Article
- Acinetobacter baumannii producing OXA-23 detected in the Czech Republic.SpringerPlus · 2013Article
- Imipenem-resistant Acinetobacter baumannii carrying the ISAba1-bla OXA-23,51 and ISAba1-bla ADC-7 genes in Monteria, Colombia.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2012Article
- First identification of OXA-72 carbapenemase from Acinetobacter pittii in Colombia.Antimicrobial agents and chemotherapy · 2012Article
- Article
- Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar.Annals of clinical microbiology and antimicrobials · 2010Article
- Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm?Journal of medicinal chemistry · 2010Article
- Diversity, epidemiology, and genetics of class D beta-lactamases.Antimicrobial agents and chemotherapy · 2010Review
- Carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme: dissemination in Southern Brazil.Infection · 2009Article
- Acinetobacter baumannii: emergence of a successful pathogen.Clinical microbiology reviews · 2008Review
- Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.Antimicrobial agents and chemotherapy · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During 2005, 66 carbapenem-resistant isolates of Acinetobacter baumannii were collected from seven tertiary-care hospitals participating in a nationwide surveillance network in Colombia. The isolates were multidrug resistant and produced the carbapenemases OXA-23 and OXA-51. Forty-five belonged to four clones while 21 were unique pulsotypes. One clone was present in two hospitals within one city, while another had spread between two hospitals in different cities. Blood, secretions, and abdominal fluids were the most frequent sites of isolation. This is the first description of widespread dissemination of OXA-23 in South America.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.